59 related articles for article (PubMed ID: 22584851)
1. B cell non-Hodgkin's lymphoma: experience from a tertiary care cancer center.
Prakash G; Sharma A; Raina V; Kumar L; Sharma MC; Mohanti BK
Ann Hematol; 2012 Oct; 91(10):1603-11. PubMed ID: 22584851
[TBL] [Abstract][Full Text] [Related]
2. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.
Patte C; Auperin A; Gerrard M; Michon J; Pinkerton R; Sposto R; Weston C; Raphael M; Perkins SL; McCarthy K; Cairo MS;
Blood; 2007 Apr; 109(7):2773-80. PubMed ID: 17132719
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of clinical and prognostic factors for primary gastric diffuse large B-cell lymphoma: Single-center experience.
Bardakci M; Esmer DD; Hafizoglu E; Karaman K; Kuzu OF; Karakas H; Gungorer B; Uncu D
J Cancer Res Ther; 2023; 19(3):778-782. PubMed ID: 37470610
[TBL] [Abstract][Full Text] [Related]
4. Primary diffuse large B-cell lymphoma of the vulva: a case report.
Kim SY; Koo JH; Lee J; Koo YJ; Gu MJ; Lee DH
J Yeungnam Med Sci; 2023 Nov; 40(Suppl):S87-S92. PubMed ID: 37096360
[TBL] [Abstract][Full Text] [Related]
5. Primary bone lymphoma: Clinical presentation and therapeutic considerations.
Müller A; Dreyling M; Roeder F; Baur-Melnyk A; Knösel T; Klein A; Birkenmaier C; Jansson V; Dürr HR
J Bone Oncol; 2020 Dec; 25():100326. PubMed ID: 33083218
[TBL] [Abstract][Full Text] [Related]
6. Overview and outcome of Hodgkin's Lymphoma: Experience of a single developing country's oncology centre.
Shamoon RP; Ali MD; Shabila NP
PLoS One; 2018; 13(4):e0195629. PubMed ID: 29649329
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Factors and Outcomes of Early-Stage Hodgkin's Lymphoma: Multi-Institutional Data From South India.
Singuluri LS; Jayachandran PK; Goenka L; Shenoy PK; Rathnam KK; Seshachalam A; Mehra N; Kumar MR; Suseela MM; Raghavan V; Nair CK; Dubashi B; Dhanushkodi M; Ganesan P
Indian J Hematol Blood Transfus; 2024 Apr; 40(2):237-245. PubMed ID: 38708161
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Impact of Baseline Immunologic Profile in Aggressive B-cell non-Hodgkin's Lymphomas.
Ramadan S; Ceparano G; Cignetti A; Sammassimo S; Bagnardi V; Pagan E; Gottardi D; Fiori S; Passerini R; Radice T; Saglio G; Tarella C
Mediterr J Hematol Infect Dis; 2021; 13(1):e2021018. PubMed ID: 33747399
[TBL] [Abstract][Full Text] [Related]
9. Adult Ileoileal Intussusception Caused by Diffuse Large B-cell Lymphoma
Louis-Jean S; Chaudhry S; Richards S
J Community Hosp Intern Med Perspect; 2023; 13(6):1-4. PubMed ID: 38596539
[TBL] [Abstract][Full Text] [Related]
10. Outcome as a measure of quality of care in oncology: experience at sultan qaboos university hospital, oman.
Burney IA; Al Moundhri MS; Rizvi AJ; Ganguly SS; Al Abri R; Ashrafi RA
Sultan Qaboos Univ Med J; 2008 Mar; 8(1):27-36. PubMed ID: 21654954
[TBL] [Abstract][Full Text] [Related]
11. Challenges in Administering Salvage Therapy and Outcomes of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients: A LMIC Real-World Study.
Singh C; Jandial A; Jain A; Lad D; Khadwal A; Basher R; Bal A; Malhotra P; Prakash G
Indian J Hematol Blood Transfus; 2024 Apr; 40(2):231-236. PubMed ID: 38708153
[TBL] [Abstract][Full Text] [Related]
12. Association between serum albumin levels and survival in elderly patients with diffuse large B-cell lymphoma: a single-center retrospective study.
Hu X; Feng X; Wang H; Miao Y; Lian X; Gao Q; Gao Y; Zhai X; Zhang D; Niu B; Wang Y
Transl Cancer Res; 2023 Jun; 12(6):1577-1587. PubMed ID: 37434675
[TBL] [Abstract][Full Text] [Related]
13. Expression of Neuron-Specific Enolase and Other Neuroendocrine Markers is Correlated with Prognosis and Response to Therapy in Non-Hodgkin Lymphoma.
Chowdhury S; Kataria SP; Yadav AK
J Lab Physicians; 2022 Dec; 14(4):427-434. PubMed ID: 36531550
[No Abstract] [Full Text] [Related]
14. Improving outcomes for high-risk DLBCL: a pilot study looking at the role of fractionated cyclophosphamide with RCHOP chemo-immunotherapy (SCUBA-1 trial).
Singh C; Malhotra P; Jandial A; Jain A; Lad D; Khadwal A; Bal A; Das A; Mittal BR; Prakash G
Indian J Hematol Blood Transfus; 2023 Jan; 39(1):77-84. PubMed ID: 36091934
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic Stem Cell Transplant for Hematological Malignancies: Experience from a Tertiary Care Center in Northern India and Review of Indian Data.
Sharma SK; Choudhary D; Doval D; Khandelwal V; Setia R; Dadu T; Handoo A
South Asian J Cancer; 2022 Jan; 11(1):62-67. PubMed ID: 35833052
[TBL] [Abstract][Full Text] [Related]
16. Impact of C-reactive protein and albumin levels on short, medium, and long term mortality in patients with diffuse large B-cell lymphoma.
Gradel KO; Larsen TS; Frederiksen H; Vinholt PJ; Iachina M; Póvoa P; Zampieri FG; Nielsen SL; Dessau RB; Møller JK; Jensen TG; Chen M; Coia JE; Jelicic J
Ann Med; 2022 Dec; 54(1):713-722. PubMed ID: 35238275
[No Abstract] [Full Text] [Related]
17. Diffuse Large B-Cell Lymphoma: Clinical Presentation and Treatment Outcomes From the
Nair R; Bhurani D; Rajappa S; Kapadia A; Reddy Boya R; Sundaram S; Menon H; Raman GS; Seshachalam A; Nimmagadda R
Front Oncol; 2021; 11():796962. PubMed ID: 35186714
[TBL] [Abstract][Full Text] [Related]
18. Successful Use of High Dose Methotrexate in Treatment of Primary CNS Lymphoma Patients Without Access to Serum Methotrexate Levels Monitoring: Challenges and Outcome.
Singh C; Jain A; Takkar A; Agarwal A; Rohilla M; Lad D; Khadwal A; Basher R; Radotra BD; Bal A; Das A; Gupta V; Lal V; Varma S; Malhotra P; Prakash G
Indian J Hematol Blood Transfus; 2022 Jan; 38(1):68-77. PubMed ID: 35125713
[TBL] [Abstract][Full Text] [Related]
19. Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India.
Gogia A; Nair S; Arora S; Kumar L; Sharma A; Gupta R; Biswas A; Mallick S
Front Oncol; 2021; 11():770747. PubMed ID: 34926277
[TBL] [Abstract][Full Text] [Related]
20. Agent Repurposing for the Treatment of Advanced Stage Diffuse Large B-Cell Lymphoma Based on Gene Expression and Network Perturbation Analysis.
Xiang C; Ni H; Wang Z; Ji B; Wang B; Shi X; Wu W; Liu N; Gu Y; Ma D; Liu H
Front Genet; 2021; 12():756784. PubMed ID: 34721544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
